These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6145013)

  • 1. Disease flare induced by luteinising hormone releasing hormone analogues in cancer patients.
    Deghenghi R; Misset JL
    Lancet; 1984 Jun; 1(8389):1302. PubMed ID: 6145013
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.
    Waxman J; Man A; Hendry WF; Whitfield HN; Besser GM; Tiptaft RC; Paris AM; Oliver RT
    Br Med J (Clin Res Ed); 1985 Nov; 291(6506):1387-8. PubMed ID: 2933122
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dramatic aggravation of prostatic cancer at the onset of treatment with an LHRH agonist].
    Boumier P; Koeger AC; Camus JP
    Presse Med; 1985 May; 14(21):1200-1. PubMed ID: 3158996
    [No Abstract]   [Full Text] [Related]  

  • 4. Disease flare induced by D-Trp6-LHRH analogue in patients with metastatic prostatic cancer.
    Kahan A; Delrieu F; Amor B; Chiche R; Steg A
    Lancet; 1984 Apr; 1(8383):971-2. PubMed ID: 6143912
    [No Abstract]   [Full Text] [Related]  

  • 5. Metastatic carcinoma of the prostate in both testes of patients treated with LH-RH analogues.
    Hadjissotiriou GG; Papadopoulos S; Rebelakos A
    Br J Urol; 1992 Jun; 69(6):657-9. PubMed ID: 1386273
    [No Abstract]   [Full Text] [Related]  

  • 6. Gonadotrophin hormone releasing analogues open new doors in cancer treatment.
    Waxman J
    Br Med J (Clin Res Ed); 1987 Oct; 295(6606):1084-5. PubMed ID: 2961401
    [No Abstract]   [Full Text] [Related]  

  • 7. Deslorelin. D-Trp-LHRH-PEA, LHRH agonist analogue, Somagard.
    Drugs R D; 1999 Dec; 2(6):420-2. PubMed ID: 10763456
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aggravation of obstructive renal insufficiency by prostatic cancer treated with a gonadorelin agonist].
    Kerbrat P; Toussaint C; Gedouin D; Lobel B
    Presse Med; 1986 Feb; 15(4):165. PubMed ID: 2938124
    [No Abstract]   [Full Text] [Related]  

  • 9. LHRH analogues in prostatic cancer.
    Lancet; 1986 Feb; 1(8478):445-6. PubMed ID: 2868364
    [No Abstract]   [Full Text] [Related]  

  • 10. Gonadotrophin-releasing hormone agonists induce osteoporosis.
    Maillefert JF; Sibilia J; Kuntz JL; Tavernier C
    Br J Rheumatol; 1994 Dec; 33(12):1199-200. PubMed ID: 8000764
    [No Abstract]   [Full Text] [Related]  

  • 11. How would you like to have an orchidectomy for advanced prostatic cancer?
    Parmar H; Phillips RH; Lightman SL; Edwards L
    Am J Clin Oncol; 1988; 11 Suppl 2():S160-8. PubMed ID: 2977271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term treatment with luteinising hormone releasing hormone agonists and maintenance of serum testosterone to castration concentrations.
    Labrie F; Dupont A; Belanger A; Lachance R; Giguere M
    Br Med J (Clin Res Ed); 1985 Aug; 291(6492):369-70. PubMed ID: 3926197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early tumor exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone.
    Parmar H; Phillips RH; Lightman SL; Edwards L
    Br Med J (Clin Res Ed); 1985 Dec; 291(6509):1645. PubMed ID: 2934109
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical or surgical orchidectomy.
    Parmar H; Edwards LE; Phillips RH; Charlton C; Lightman SI
    BMJ; 1991 May; 302(6787):1272. PubMed ID: 1828382
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of a long acting luteinizing hormone releasing hormone agonist (Decapeptyl) and orchiectomy in the treatment of advanced prostatic cancer. Preliminary report.
    De Sy WA; de Meyer JM; Casselman J; De Smet R; Renders G; Schelfhout W; De Wilde P
    Acta Urol Belg; 1986; 54(2):221-9. PubMed ID: 2942015
    [No Abstract]   [Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone analogs and prostatic cancer.
    Swanson LJ; Seely JH; Garnick MB
    Crit Rev Oncol Hematol; 1988; 8(1):1-26. PubMed ID: 2964939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic carcinoma with lung metastases in a former bagasse worker; LH-RH analogs as an alternative therapy.
    Comaru-Schally AM; Kushner DS
    Am J Med Sci; 1988 Nov; 296(5):348-53. PubMed ID: 2973752
    [No Abstract]   [Full Text] [Related]  

  • 18. Luteinizing hormone-releasing hormone analogues in the treatment of prostate cancer.
    Crawford ED; Davis MA
    Cancer Treat Res; 1988; 39():25-38. PubMed ID: 2908606
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.
    Kerle D; Williams G; Ware H; Bloom SR
    Br Med J (Clin Res Ed); 1984 Aug; 289(6443):468-9. PubMed ID: 6235888
    [No Abstract]   [Full Text] [Related]  

  • 20. New gonadotropin-releasing hormone glycolipids with direct antiproliferative activity and gonadotropin-releasing potency.
    Varamini P; Mansfeld FM; Giddam AK; Steyn F; Toth I
    Int J Pharm; 2017 Apr; 521(1-2):327-336. PubMed ID: 28232269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.